eMedicine Specialties > Dermatology > Reactive & Inflammatory Dermatoses

Asteatotic Eczema

Author: Christina K Anderson, MD, Consulting Staff, Department of Dermatology, Center Care Clinic
Coauthor(s): O Fred Miller III, MD, Emeritus Director, Department of Dermatology, Geisinger Medical Center; Susan Cooper, MB, ChB, MD, MRCGP, MRCP, Consultant Dermatologist and Honorary senior clinical lecturer Department of Dermatology, Churchill Hospital, Oxford, United Kingdom
Contributor Information and Disclosures

Updated: Sep 11, 2009

Introduction

Background

First described by Brocq in 1907, using the term eczema craquelé, asteatotic dermatitis is characterized by pruritic, dry, cracked, and polygonally fissured skin with irregular scaling. It most commonly occurs on the shins of elderly patients, but it may occur on the hands and the trunk.

In 1971, Domonkos described the appearance of this dermatitis as cracked porcelain. The pattern of cracking has been likened to a crazy pavement pattern. In 1999, Fitzpatrick likened asteatotic eczema to a dried-up riverbed. According to Caplan, superficial bleeding and fissures can occur as the epidermis loses water, as it splits, and as it cracks deeply enough to disrupt papillary dermal capillaries. The inflammation can be associated with asymmetric leg edema. Eczema with increased lichenification occasionally supervenes as patients rub and scratch the pruritic areas.

The eruption can be generalized or localized. Generalized asteatosis is a distinct entity and should provoke a search for possible associated diseases. Guillet divides the localized forms into 4 types:

  • Asteatotic eczema of the lower extremities in elderly persons secondary to aging, dehydrated skin, and malnutrition
  • Cracked erythema secondary to irritant contact dermatitis from soaps or detergents
  • Eczema craquelé in areas in which corticosteroid therapy was discontinued
  • Asteatotic eczema in neurologic disorders

Pathophysiology

Initially, excess water loss from the epidermis results in dehydration of the stratum corneum with upward curling of corneocytes. The outer keratin layers require 10-20% water concentration to maintain their integrity. A significant decrease in free fatty acids in the stratum corneum is present in people with asteatotic dermatitis. Stratum corneum lipids act as water modulators, and cutaneous loss of these lipids can increase transepidermal water loss to 75 times that of healthy skin.1 Elderly persons with decreased sebaceous and sweat gland activity, patients on antiandrogen therapy, people using degreasing agents, and people bathing without replacing natural skin emollients lost to bath water are at risk for asteatotic eczema.

When the stratum corneum loses water, the cells shrink. A significantly decreased cellular volume can stress the skin's elasticity, creating fissures. Edema in the dermis leads to additional stretch on the overlying epidermis. Fissures rupture dermal capillaries, causing clinical bleeding. The disruption of cutaneous integrity can result in inflammation with risk of infection. Transepidermal absorption of allergens and irritants is increased as the epidermis is damaged, increasing susceptibility to allergic contact dermatitis and irritant contact dermatitis.2 Allergic contact dermatitis and irritant contact dermatitis may cause a persistent and possibly more extensive dermatitis despite therapy. Furthermore, low environmental humidity contributes to xerosis, creating a clinical picture of asteatotic dermatitis in some dermatologic conditions, such as atopic dermatitis.

Frequency

United States

Seasonality is prominent, and most patients present in the winter months, especially in areas where indoor humidity is decreased by heating. The frequency of asteatotic dermatitis is increased in the northern United States, particularly during the winter season.

Mortality/Morbidity

Although most cases resolve without ill effects, asteatotic dermatitis can be chronic with relapses frequent during the winter months and during times of low humidity.

Sex

Men older than 60 years develop asteatotic dermatitis more commonly than women.

Age

The median patient age at presentation is 69 years. Asteatosis can also occur in young people.

Clinical

History

During the winter months, an elderly person classically presents with pruritic and dry skin with dermatitis on the pretibial areas. Sometimes, the dysesthesia may be described as a pinprick or biting sensation.

  • Asking the patient about pertinent controllable factors, such as the following, is important:
    • Frequency of bathing, showering, and cleansing, and which soaps and cleansers are in contact with the skin
    • Types of skin lubricants used, and method and frequency of application
    • Diet
    • Medications
    • Types of clothing worn (Wool may cause irritation.)
    • The source, the type, and the temperature of heat that may alter the humidity of the environment
  • If the eruption persists despite therapy, behavioral changes, and treatment compliance, allergic contact dermatitis and irritant contact dermatitis and internal malignancy may require investigation.

Physical

  • Primary lesions: Slightly scaly, inflamed, curvilinearly cracked and/or fissured skin most commonly involves the pretibial areas, but it may also occur on the thighs, on the hands, and on the trunk (see Media File 1).
Asteatotic dermatitis on the lower extremity.

Asteatotic dermatitis on the lower extremity.

Asteatotic dermatitis on the lower extremity.

Asteatotic dermatitis on the lower extremity.

  • Secondary lesions
    • Excoriated, erythematous, edematous patches may result from rubbing or scratching.
    • Bleeding fissures secondary to the disruption of dermal capillaries have been described in exaggerated eczema craquelé, which begins as superficial cracks in the epidermis.
  • Generalized lesions: Generalized or extensive asteatotic dermatitis presents with primary lesions and secondary excoriations (see Media Files 2-3).
Asteatotic dermatitis on the lower extremity.

Asteatotic dermatitis on the lower extremity.

Asteatotic dermatitis on the lower extremity.

Asteatotic dermatitis on the lower extremity.


Asteatotic dermatitis on the lower extremity.

Asteatotic dermatitis on the lower extremity.

Asteatotic dermatitis on the lower extremity.

Asteatotic dermatitis on the lower extremity.


Causes

Multiple etiologic factors may coexist to cause asteatotic dermatitis, including the following:

  • Xerosis and friction
  • Frequent or prolonged bathing in hot water, use of soap on the involved site, and infrequent use of emollients for water retention in the stratum corneum
  • Degreasing agents
    • Solvents
    • Cleansers
  • Decreased sebaceous and sweat gland activity in elderly persons
  • Decreased keratin synthesis in elderly persons
  • Low environmental humidity and cold winds that increase the loss of water by convection
  • Radiation
  • Long-term malabsorption of essential fatty acids, including linoleic acid and linolenic acid
  • Nutritional deficiencies
    • Zinc deficiency3
    • Essential fatty acid deficiency, such as linoleic acid deficiency or linolenic acid deficiency
  • Atopy
  • Ichthyosis
  • Thyroid disease - Myxedema and other thyroid diseases with diminished sweat and sebaceous gland activity4
  • Neurologic disorders - Decreased sweating in denervated areas
  • Drugs - Antiandrogen therapy5 and diuretic therapy
  • Malignancies - Malignant lymphoma,6 gastric adenocarcinoma,7 glucagonoma, angioimmunoblastic lymphadenopathy,8 breast cancer, large-cell lung carcinoma, and colorectal carcinoma9

More on Asteatotic Eczema

Overview: Asteatotic Eczema
Differential Diagnoses & Workup: Asteatotic Eczema
Treatment & Medication: Asteatotic Eczema
Follow-up: Asteatotic Eczema
Multimedia: Asteatotic Eczema
References

References

  1. Akimoto K, Yoshikawa N, Higaki Y, Kawashima M, Imokawa G. Quantitative analysis of stratum corneum lipids in xerosis and asteatotic eczema. J Dermatol. Jan 1993;20(1):1-6. [Medline].

  2. Cork MJ, Danby S. Skin barrier breakdown: a renaissance in emollient therapy. Br J Nurs. Jul 23-Aug 12 2009;18(14):872, 874, 876-7. [Medline].

  3. Weismann K, Wadskov S, Mikkelsen HI, Knudsen L, Christensen KC, Storgaard L. Acquired zinc deficiency dermatosis in man. Arch Dermatol. Oct 1978;114(10):1509-11. [Medline].

  4. Warin AP. Eczéma craquelé as the presenting feature of myxoedema. Br J Dermatol. Sep 1973;89(3):289-91. [Medline].

  5. Greist MC, Epinette WW. Cimetidine-induced xerosis and asteatotic dermatitis. Arch Dermatol. Apr 1982;118(4):253-4. [Medline].

  6. Barker DJ, Cotterill JA. Generalized eczéma craquelé as a presenting feature of lymphoma. Br J Dermatol. Sep 1977;97(3):323-6. [Medline].

  7. Guillet MH, Schollhammer M, Sassolas B, Guillet G. Eczema craquelé as a pointer of internal malignancy--a case report. Clin Exp Dermatol. Nov 1996;21(6):431-3. [Medline].

  8. van Voorst Vader PC, Folkers E, van Rhenen DJ. Craquelé-like eruption in angioimmunoblastic lymphadenopathy. Arch Dermatol. Mar 1979;115(3):370. [Medline].

  9. Higgins EM. Eczema craquelé and internal malignancy. Clin Exp Dermatol. Jul 1997;22(4):206. [Medline].

  10. Lazar AP, Lazar P. Dry skin, water, and lubrication. Dermatol Clin. Jan 1991;9(1):45-51. [Medline].

  11. Cappiello L, Miller OF. Occlusive therapy of asteatotic dermatitis. Data presented at: Pennsylvania Academy of Dermatology: 1990.

  12. Day I, Lin AN. Use of pimecrolimus cream in disorders other than atopic dermatitis. J Cutan Med Surg. Jan-Feb 2008;12(1):17-26. [Medline].

  13. Wollina U. The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis. Am J Clin Dermatol. 2007;8(3):157-73. [Medline].

  14. Schulz P, Bunselmeyer B, Brautigam M, Luger TA. Pimecrolimus cream 1% is effective in asteatotic eczema: results of a randomized, double-blind, vehicle-controlled study in 40 patients. J Eur Acad Dermatol Venereol. Jan 2007;21(1):90-4. [Medline].

  15. Gutman AB, Kligman AM, Sciacca J, James WD. Soak and smear: a standard technique revisited. Arch Dermatol. Dec 2005;141(12):1556-9. [Medline].

  16. Burton J, Holden C. Eczema, lichenification, and prurigo. In: Textbook of Dermatology. Vol 1. 6th ed. Oxford, England: Blackwell Science; 1998:644-45.

  17. Caplan RM. Superficial hemorrhagic fissures of the skin. Arch Dermatol. Apr 1970;101(4):442-51. [Medline].

  18. Fitzpatrick T, Johnson R, Wolff K. Asteatotic Dermatitis. In: Color Atlas and Synopsis of Clinical Dermatology. 3rd ed. New York, NY: McGraw-Hill; 1997:75.

  19. Murray H, Forsey RR. Eczema craquele. Arch Dermatol. 1975;111:1536.

Further Reading

Keywords

asteatotic eczema, asteatotic dermatitis, eczema craquelé, asteatosis, eczema craquelatum, xerotic eczema, winter itch, eczema hiemalis, eczema fendille, etat craquelé

Contributor Information and Disclosures

Author

Christina K Anderson, MD, Consulting Staff, Department of Dermatology, Center Care Clinic
Christina K Anderson, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

Coauthor(s)

O Fred Miller III, MD, Emeritus Director, Department of Dermatology, Geisinger Medical Center
O Fred Miller III, MD is a member of the following medical societies: American Academy of Dermatology and Pennsylvania Medical Society
Disclosure: Nothing to disclose.

Susan Cooper, MB, ChB, MD, MRCGP, MRCP, Consultant Dermatologist and Honorary senior clinical lecturer Department of Dermatology, Churchill Hospital, Oxford, United Kingdom
Susan Cooper, MB, ChB, MD, MRCGP, MRCP is a member of the following medical societies: Royal College of Physicians
Disclosure: Nothing to disclose.

Medical Editor

Abby S Van Voorhees, MD, Assistant Professor, Director of Psoriasis Services and Phototherapy Units, Department of Dermatology, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania
Abby S Van Voorhees, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, National Psoriasis Foundation, Phi Beta Kappa, Sigma Xi, and Women's Dermatologic Society
Disclosure: Amgen Honoraria Consulting; Abbott Honoraria Consulting; Genentech Honoraria Consulting; Incyte Grant/research funds Other; Warner Chilcott Honoraria Consulting; Merck Salary Management position; Abbott  Speaking and teaching

Pharmacy Editor

Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center
Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Christen M Mowad, MD, Associate Professor, Department of Dermatology, Geisinger Medical Center
Christen M Mowad, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, and Phi Beta Kappa
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.